Effects of continuous high-volume hemofiltration on experimental severe acute pancreatitis in pigs

Pancreas

Volumn 34, Issue 1, 2007, Pages 112-119

  Li, Weiqin ^a   Yan, Xiaowen ^a   Wang, Hao ^a   Zhang, Zhenhuan ^a   Yu, Wenkui ^a   Ji, Daxi ^a   Gong, Dehua ^a   Quan, Zhufu ^a   Li, Jieshou ^a,b  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

Continuous high volume hemofiltration; Pigs; Severe acute pancreatitis

Indexed keywords

AMYLASE; CHLORINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MODEL; DISEASE SEVERITY; ENZYME ACTIVITY; EXPERIMENTAL STUDY; HEMODYNAMIC MONITORING; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HYPOTENSION; HYPOTHERMIA; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; SURVIVAL TIME; SWAN GANZ CATHETER; SWINE; SYSTEMIC VASCULAR RESISTANCE; URINE VOLUME;

ACUTE DISEASE; AMYLASES; ANIMALS; BLOOD PRESSURE; BODY TEMPERATURE; CARDIAC OUTPUT; CENTRAL VENOUS PRESSURE; CYTOKINES; HEART RATE; HEMOFILTRATION; HYPOTENSION; LIPASE; PANCREATITIS; PULMONARY WEDGE PRESSURE; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SWINE; URINE; VASCULAR RESISTANCE;

EID: 33846024035     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000240605.03441.1f     Document Type: Article

References (29)

1. Banks PA. Acute pancreatitis: medical and surgical management. Am J Gastroenterol. 1994;89(8):S78-S85.
2. Ruffell AJ. The utilization of continuous veno-venous hemofiltration for the removal of septic mediators in patients with systemic inflammatory response syndrome. Intensive Crit Care Nurs. 2003;19(4):207-214.
3. Yonekawa M. Cytokine and endotoxin removal in critically ill patients. Ther Apher Dial. 2005;9(5):A37.
4. Heering P, Grabensee B, Brause M. Cytokine removal in septic patients with continuous venovenous hemofiltration. Kidney Blood Press Res. 2003;26(2):128-134.
5. Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis. 2004;43(3):444-456.
6. Honore PM, Joannes-Boyau O. High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs. 2004;27(12):1077-1082.
7. Innes J, Fraser I, Carey LC. The vasoactive properties of ascitic fluid in acute pancreatitis in a porcine model. Arch Surg. 1986;121(6):665-668.
8. Wang H, Zhang ZH, Yan XW, et al. Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol. 2005;7;11(1):127-31.
9. Pupelis G. Renal failure in acute pancreatitis. Timing of dialysis and surgery. Przegl Lek. 2000;(57 suppl 5):29-31.
10. Beger HG, Rau B, Mayer J, et al. Natural course of acute pancreatitis. World J Surg. 1997;21:130-135.
11. Nathens AB, Curtis JR, Beale RJ, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med. 2004;32(12):2524-2536.
12. Papachristou GI, Whitcomb DC. Inflammatory markers of disease severity in acute pancreatitis. Clin Lab Med. 2005;25(1):17-37.
13. Bhatia M, Wong FL, Cao Y, et al. Pathophysiology of acute pancreatitis. Pancreatology. 2005;5(2-3):132-144.
14. Gomez-Cambronero LG, Sabater L, Pereda J, et al. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy. 2002;1(4):393-403.
15. Pupelis G, Austrums E, Snippe K. Blood purification methods for treatment of organ failure in patients with severe pancreatitis. Zentralbl Chir. 2001;126(10):780-784.
16. Wang H, Li WQ, Zhou W, et al. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol. 2003;9(9):2096-2099.
17. Yang Z, Wang C, Tao J, et al. Effect of early hemofiltration on pro- and anti-inflammatory responses and multiple organ failure in severe acute pancreatitis. J Huazhong Univ Sci Technolog Med Sci. 2004;24(5):456-459.
18. Yang ZH, Yang J, Wang YJ. Protective effect of continuous veno-venous hemofiltration on tissue and organ in patients with severe acute pancreatitis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004;16(4):232-234.
19. Blinzler L, Hausser J, Bodeker H, et al. Conservative treatment of severe necrotizing pancreatitis using early continuous venovenous hemofiltration. Contrib Nephrol. 1991;93:234-236.
20. Yekebas EF, Treede H, Knoefel WT, et al. Influence of zero-balanced hemofiltration on the course of severe experimental pancreatitis in pigs. Ann Surg. 1999;229:514-522.
21. Clark WR, Turk JE, Kraus MA, et al. Dose determinants in continuous renal replacement therapy. Artif Organs. 2003;27(9):815-820.
22. Lonnemann G, Bechstein M, Linnenweber S, et al. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl. 1999;72:S84-S87.
23. Bellomo R, Baldwin I, Cloe L, et al. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int. 1998;53(S66):182-185.
24. Ronco C, Tetta C, Mariano F, et al. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs. 2003;27(9):792-801.
25. Ullrich R, Roeder G, Lorber C, et al. Continuous venovenous hemofiltration improves arterial oxygenation in endotoxin-induced lung injury in pigs. Anesthesiology. 2001;95:428-436.
26. Yan XW, Li WQ, Wang H, et al. Effect of high-volume continuous hemofiltration on experimental pancreatitis associated lung injury in pigs. Int J Artif Organs. 2006;29(3):293-302.
27. Yekebas EF, Strate T, Zolmajd S, et al. Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int. 2002;62(5):1806-1818.
28. Rogiers P, Zhang H, Smail N, et al. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med. 1999;27:1848-1855.
29. Rogiers P, Zhang H, Pauwels D, et al. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Crit Care Med. 2003;31(4):1219-1225.